文献速递小儿麻醉心胸血管麻醉

右美托咪定对全麻患儿心肌复极化的影响:随机对照试验

Effects of Dexmedetomidine on Myocardial Repolarization in Children Undergoing General Anesthesia: A Randomized Controlled Trial.
PubMed 文献 · Anesth Analg · 2019-01-01

结果显示各剂量对Tp-e无影响(F=0.09;P=.96),0.5和0.75 µg/kg组校正QT间期缩短,无心律失常发生。

要点

  • 右美托咪定0.25-0.75 µg/kg推注不影响患儿Tp-e(跨壁离散度)。
  • 0.5和0.75 µg/kg右美托咪定使校正QT间期缩短,对照组则延长。
  • 研究中未观察到心律失常,无证据提示增加尖端扭转型室速风险。

核心结论

  • 所研究的右美托咪定推注剂量均不影响Tp-e,0.5和0.75 µg/kg剂量在推注后1分钟缩短校正QT间期,无证据提示增加尖端扭转型室速风险。

研究设计与样本

  • 干预前后记录12导联心电图,由不知分组的小儿电生理医生测量Tp-e和校正QT间期,采用协方差分析回归模型,研究效能设定为检测Tp-e 25毫秒差异。

主要发现

  • 无心律失常发生。
  • Tp-e值不受任何研究剂量右美托咪定影响(F=0.09;P=.96),组内平均(99%CI)差异均<2毫秒(-5至8)。
  • 干预后校正QT间期在对照组增加,而在部分右美托咪定组降低(F=7.23;P<.001),具体为0.5和0.75 µg/kg剂量组。
  • 组内干预前后校正QT间期平均(99%CI)差异:对照组12.4毫秒(-5.8至30.6),右美托咪定0.25 µg/kg组-9.0毫秒(-24.9至6.9),0.5 µg/kg组-18.6毫秒(-33.7至-3.5),0.75 µg/kg组-14.1毫秒(-27.4至-0.8)。

临床怎么用

  • 在3-10岁ASA I-II级患儿全麻中,右美托咪定0.25-0.75 µg/kg单次推注未显示对心肌复极化的不良影响,0.5和0.75 µg/kg可缩短校正QT间期。

局限性

  • 最终分析样本量较小(每组12例),研究效能仅针对Tp-e 25毫秒差异设定。
  • 校正QT间期测量时间为右美托咪定推注后1分钟,未报告其他时间点数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dexmedetomidine is a highly selective α2-adrenergic agonist, which is increasingly used in pediatric anesthesia and intensive care. Potential adverse effects that have not been rigorously evaluated in children include its effects on myocardial repolarization, which is important given that the drug is listed as a possible risk factor for torsades de pointes. We investigated the effect of 3 different doses of dexmedetomidine on myocardial repolarization and transmural dispersion in children undergoing elective surgery with total IV anesthesia. METHODS: Sixty-four American Society of Anesthesiologists I-II children 3-10 years of age were randomized to receive dexmedetomidine 0.25 µg/kg, 0.5 µg/kg, 0.75 µg/kg, or 0 µg/kg (control), as a bolus administered over 60 seconds, after induction of anesthesia. Pre- and postintervention 12-lead electrocardiograms were recorded. The interval between the peak and the end of the electrocardiogram T wave (Tp-e; transmural dispersion) and heart rate-corrected QT intervals (myocardial repolarization) were measured by a pediatric electrophysiologist blinded to group allocation. Data were analyzed using an analysis of covariance regression model. The study was powered to detect a 25-millisecond difference in Tp-e. RESULTS: Forty-eight children completed the study, with data analyzed from 12 participants per group. There were no instances of dysrhythmias. Tp-e values were unaffected by dexmedetomidine administration at any of the studied doses (F = 0.09; P = .96). Mean (99% CI) within-group differences were all <2 milliseconds (-5 to 8). Postintervention, corrected QT interval increased in the control group, but decreased in some dexmedetomidine groups (F = 7.23; P < .001), specifically the dexmedetomidine 0.5 and 0.75 µg/kg doses. Within groups, the mean (99% CI) differences between pre- and postintervention corrected QT interval were 12.4 milliseconds (-5.8 to 30.6) in the control group, -9.0 milliseconds (-24.9 to 6.9) for dexmedetomidine 0.25 µg/kg, -18.6 milliseconds (-33.7 to -3.5) for dexmedetomidine 0.5 µg/kg, and -14.1 milliseconds (-27.4 to -0.8) for dexmedetomidine 0.75 µg/kg. CONCLUSIONS: Of the bolus doses of dexmedetomidine studied, none had an effect on Tp-e and the dexmedetomidine 0.5 and 0.75 µg/kg doses shortened corrected QT intervals when measured at 1 minute after dexmedetomidine bolus injection during total IV anesthesia. There is no evidence for an increased risk of torsades de pointes in this context.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Görges M, Sherwin ED, Poznikoff AK, et al. Effects of Dexmedetomidine on Myocardial Repolarization in Children Undergoing General Anesthesia: A Randomized Controlled Trial. Anesth Analg. 2019. PMID: 30985379. doi:10.1213/ANE.0000000000004135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。